Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

Alaris Syringe Pump, Model No. 8110. Delivers fluids. Expansion of Affected Units: BOM Housing Assembly Service, Part No. 49000226, and Lower Housing/Carriage Block Assembly, Part No. 148188-100.

FDA Recall Z-2362-2015 · Posted 2015-08-14

Recalling FirmCareFusion 303, Inc.
Recall StatusTerminated
Product CodeFRN
Date Initiated2015-07-21
Date Terminated2018-12-14
Product Quantity68,460 units

Reason for Recall

Channel Error code is displayed on the PC unit with an audio and visual alarm, and on the syringe module. After the error is cleared on the PCU, the syringe pump is unresponsive to key presses until the next power cycle, or the module is detached and reattached.

Firm Action

An Urgent Medical Device Recall Notification letter was sent on 7/20/15 to customers who purchased the Alaris Syringe Module (Model 8110) to inform them that CareFusion has identified an issue with the Alaris Syringe module manufactured between March 2014 through September 2014. The letter informs customers of the problems identified and the actions to be taken. CareFusion will replace the syringe drive train assembly on the affected units and adjust, if required. CareFusion will contact all affected customers within 60 days to initiate the scheduling process for the remediation. Customers are instructed to contact CareFusion Support Center (888-562-6018, 7am-4pm PT, M-F, [email protected]) for recall related questions. Customers are instructed to contact Customer Advocacy (888-812-3266, 24hrs/day, 7days/wk, [email protected]) for adverse event reports. Customer are instructed to contact Technical Support (888-812-3229, 6am-5pm PT, M-F, [email protected]) for technical questions. Customers are instructed to complete and return the enclosed customer response card to expedite the corrective action process. A urgent recall letter for the expansion of the affected units was sent on 10/15/15 to inform customers of the expanded recall. The letter informs customers that the firm has identified an issue with the Alaris Syringe module model 8110 after receiving reports of customers experiencing an channel error on the Alaris Syringe module Model 8110. The letter informs customers that the recall is an expansion of affected units outlined in the CareFusion recall previously issued on 7/20/15. The letter provides the customers with the affected units, issue, potential risk, and actions to be taken. The corrective action for the expanded serial numbers will not change. The affected Alaris Syringe modules will be remediated with a hardware inspection and an adjustment, if required. CareFusion will contact all affected c

Root Cause

Process control

Distribution Pattern

Worldwide Distribution-US (nationwide) and the countries of Australia, New Zealand, South Africa, Canada, Middle East, Malaysia, and Taiwan.

Related FDA 510(k) Records

Devices referenced by this recall via K-numbers.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑